Arrhythmia Research (HRT) Q1 Profit Slips Amid Stronger Revs
Tweet
Share
E-mailGet Alerts HRT Hot Sheet
Price: $14.36 --0%
Financial Fact:
Weighted average common shares Outstanding – basic: 2.82M
Today's EPS Names:
ZEO, OTLK, EGRX, More
Financial Fact:
Weighted average common shares Outstanding – basic: 2.82M
Today's EPS Names:
ZEO, OTLK, EGRX, More
Join SI Premium – FREE
Arrhythmia Research Technology, Inc. (NYSE: HRT) reported Q1 EPS of $0.01, versus $0.04 reported last year. Revenue for the quarter came in at $6.18 million, versus $5.59 million reported last year.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Instil Bio Inc. (TIL) Misses Q2 EPS by 21c
- Reading (RDI) Tops Q2 EPS by 4c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
